RLYB – rallybio corporation (US:NASDAQ)
Stock Stats
News
Rallybio Co. (NASDAQ: RLYB) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.
Rallybio Co. (NASDAQ: RLYB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
Rallybio Co. (NASDAQ: RLYB) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $8.00 price target on the stock.
Form S-3 Rallybio Corp
Form 10-Q Rallybio Corp For: Mar 31
Form 8-K Rallybio Corp For: May 09
Form D Rallybio Corp
Form DEF 14A Rallybio Corp For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.